-
公开(公告)号:CA2972067A1
公开(公告)日:2016-07-21
申请号:CA2972067
申请日:2015-07-13
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , HSU TSUI-LING , LOU YI-WEI , LIN CHIH-WEI , YEH SHIHH-CHI , WU CHUNG-YI , WU HAN-CHUNG
Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to globo H, SSEA3, and SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, skin, bone, lungs, breast, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervical, ovarian, and/or prostate cancer.
-
公开(公告)号:AU2015206370A1
公开(公告)日:2016-07-07
申请号:AU2015206370
申请日:2015-01-16
Applicant: ACADEMIA SINICA
Inventor: LOU YI-WEI , LIN CHIH-WEI , YEH SHIH-CHI , HSU TSUI-LING , WU CHUNG-YI , WU HAN-CHUNG , WONG CHI-HUEY
IPC: C12N5/0793
Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, lung, breast, mouse, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervix, ovary, and/or prostate cancer.
-
公开(公告)号:AU2014201215B2
公开(公告)日:2016-05-05
申请号:AU2014201215
申请日:2014-03-05
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , YU ALICE , YU JOHN
IPC: A61K39/00 , A61K39/385
Abstract: The present invention provides for an immunogenic composition comprising (a) a glycan, such as Globo H, stage-specific embryonic antigen-3 (SSEA-3) or SSEA-4, conjugated to a carrier protein through a linker; (b) an adjuvant comprising a glycolipid, such as a-galactosyl-ceramide adjuvant, wherein the composition induces an immune response, such as a higher relative level of IgG isotype antibodies compared to IgM isotype antibodies, or neutralising antibodies against at least one antigen selected from the group consisting of Globo H, Gb4, SSEA-3, and SSEA-4. Uses of the immunogenic composition for treating or inhibiting tumour growth are also provided.
-
公开(公告)号:CA2950415A1
公开(公告)日:2015-12-03
申请号:CA2950415
申请日:2015-05-27
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI MING-HUNG
IPC: C07K16/00
Abstract: The present disclosure relates to a novel class of anti-CD20 monoclonal antibodies comprising a homogeneous population of anti-CD20 IgG molecules having the same N-glycan on each of Fc. The antibodies of the invention can be produced from anti-CD20 monoclonal antibodies by Fc glycoengineering. Importantly, the antibodies of the invention have improved therapeutic values with increased ADCC activity and increased Fc receptor binding affinity compared to the corresponding monoclonal antibodies that have not been glycoengineered.
-
公开(公告)号:AU2013305937A1
公开(公告)日:2015-02-19
申请号:AU2013305937
申请日:2013-08-20
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI TSUNG-I
Abstract: A novel UDP-Gal regeneration process and its combined use with a galactosyltransferease to add galactose to a suitable acceptor substrate. Also described herein are synthetic methods for generating Globo-series oligosaccharides in large scale, wherein the methods may involve the combination of a glycosyltransferase reaction and a nucleotide sugar regeneration process.
-
26.
公开(公告)号:ES2477549T3
公开(公告)日:2014-07-17
申请号:ES09798419
申请日:2009-06-16
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , WANG CHENG-CHI , YU ALICE L
IPC: G01N33/574 , G01N33/53
Abstract: Procedimiento diagnóstico de cáncer para los cánceres que son positivos para Globo H y positivos para Gb5, que comprende el suministro de una muestra que contiene anticuerpos de un sujeto del cual se sospecha que tiene cáncer, en donde dicha muestra es suero, saliva o líquido de ganglio linfático, la incubación de la muestra con Gb5 y uno o varios de Globo H, Bb2 y Bb3 para permitir que los anticuerpos de la muestra se fijen a Gb5 y a uno o varios de Globo H, Bb2 y Bb3, la medición de la cantidad de anticuerpos fijados a Gb5 y la cantidad de anticuerpos fijados a Globo H, a Bb2 o a Bb3, y la determinación de si el sujeto tiene el cáncer basándose en la cantidad de los anticuerpos fijados, en donde una proporción significativamente más alta de la cantidad de anticuerpos fijados a Globo H, Bb2 o Bb3 por la cantidad de anticuerpos fijados a Gb5, en comparación con la del sujeto sin cáncer, indica que el sujeto tiene un cáncer que es positivo para Globo H y positivo para Gb5.
-
公开(公告)号:AU2009271411B2
公开(公告)日:2013-02-07
申请号:AU2009271411
申请日:2009-06-16
Applicant: ACADEMIA SINICA
Inventor: WANG CHENG-CHI , WU CHUNG-YI , WONG CHI-HUEY , YU ALICE L
IPC: G01N33/574 , G01N33/53
Abstract: A cancer diagnostic method using a glycan array that contains Gb5 and Globo H, Bb2, Bb3, and/or Bb4.
-
公开(公告)号:NZ590064A
公开(公告)日:2012-05-25
申请号:NZ59006409
申请日:2009-06-16
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , WANG CHENG-CHI , YU ALICE L
IPC: G01N33/574 , G01N33/53
Abstract: A cancer diagnostic method that comprises the steps: (a) Providing a sample containing antibodies from a subject suspected of having cancer; (b) Incubating the sample with Gb5 and one or more of Globo H, Bb2, Bb3 and Bb4 to allow binding of the antibodies in the sample to the Gb5 and the Globo H, Bb2, Bb3 and Bb4; (c) Measuring the amount of the GB-5-bound antibodies and the amount of the Globo H-bound, Bb2-bound, Bb3-bound and Bb4-bound antibodies; (d) Determining whether the subject has the cancer based on the amounts of Gb5-bound antibodies and the Globo H-bound, Bb2-bound, Bb3-bound and Bb4-bound antibodies; The cancer is Globo H-positive and GB5-positive; and a higher ratio of the amount of Globo H-bound, Bb2-bound, Bb3-bound and Bb4-bound antibodies to the amount of Gb5-bound antibodies compared to a cancer-free subject indicates the subject has cancer. The cancer can be breast cancer, skin cancer, liver cancer, prostate cancer, ovary cancer, colon cancer, stomach cancer or pancreas cancer.
-
公开(公告)号:AU2009271411A1
公开(公告)日:2010-01-21
申请号:AU2009271411
申请日:2009-06-16
Applicant: ACADEMIA SINICA
Inventor: WANG CHENG-CHI , WU CHUNG-YI , WONG CHI-HUEY , YU ALICE L
IPC: G01N33/574 , G01N33/53
Abstract: A cancer diagnostic method using a glycan array that contains Gb5 and Globo H, Bb2, Bb3, and/or Bb4.
-
公开(公告)号:ES2902032T3
公开(公告)日:2022-03-24
申请号:ES15878250
申请日:2015-07-13
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , HSU TSUI-LING , LOU YI-WEI , LIN CHIH-WEI , YEH SHIH-CHI , WU CHUNG-YI , WU HAN-CHUNG
Abstract: Anticuerpo monoclonal humanizado aislado que se une específicamente a Neu5Acα2 → 3Galβ1 → 3GalNAcβ1 → 3Galα1 → 4Galβ1 → 4Glcβ1, en el que el anticuerpo comprende un VH que tiene la SEQ ID NO: 147 y un VL que tiene la SEQ ID NO: 148.
-
-
-
-
-
-
-
-
-